(Q43452584)
Statements
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer (English)
Thomas E Delea
Oleg Sofrygin
Simu K Thomas
Natalie L Papo
Victoria Barghout